Kidney International Review Time
Kidney International is one of the cleaner flagship-journal timing cases because official ISN materials publish concrete workflow numbers. The desk screen is fast. The real question is whether the paper deserves flagship nephrology review.
While you wait
Waiting on a decision? Get your next move ready.
The wait is out of your hands; the next move isn't. Scan your next manuscript free, or run this paper through the scan to see what reviewers typically push back on, so the revision response is ready when the decision lands.
Quick answer: Kidney International review time is clearer than many flagship medical journals because recent official International Society of Nephrology materials publish concrete workflow numbers.
The current signal is about 18 days from submission to first decision, including editorial rejects, with desk rejections averaging about 7 days, reviewed manuscripts reaching first decision in about 35 days, total time from submission to acceptance around 114 days, and acceptance to first online publication around 29 days. The practical point is that the journal is fast at deciding fit. The bigger risk is not slowness.
It is submitting a respectable nephrology paper that is too narrow for flagship nephrology (per SciRev community data and JCR latest release).
Kidney International timing signals at a glance
Those numbers are unusually actionable. Kidney International is one of the better journals to plan around because the official workflow is not hidden behind vague promises.
What the official sources do and do not tell you
The official timing numbers come from recent ISN editorial materials rather than a generic marketing blurb.
They do tell you:
- first decision is fast in aggregate
- editorial rejects are usually faster still
- the reviewed path is clearly slower than the desk path but still disciplined
- acceptance and early online publication happen on a predictable schedule
They do not tell you:
- what kinds of renal papers are most likely to be desk-rejected
- how much additional time highly technical revision rounds can add
- how much of the speed comes from hard scope filtering rather than easy generosity
That is the strategic gap authors need to fill. The journal is operationally efficient, but editorial level remains the real screen.
A practical timeline authors can actually plan around
Stage | Practical expectation | What is happening |
|---|---|---|
Initial editorial screen | About 1 week for weak-fit papers | Editors decide whether the paper deserves flagship-nephrology review |
First decision across all submissions | About 18 days | Aggregate number includes both desk and reviewed outcomes |
Reviewed first decision | About 35 days | Serious papers move into a conventional external review cycle |
Submission to acceptance | About 114 days | Successful papers often take around 4 months end to end |
Acceptance to online publication | About 29 days | Production is meaningful but not the main bottleneck |
This is a real planning timeline, not folklore. Kidney International gives authors better operational visibility than many journals at this level.
Why Kidney International can feel fast
The journal feels fast when the manuscript already looks like flagship nephrology.
The renal consequence is broad. Editors can tell quickly whether the paper matters beyond one narrow disease slice, one modality, or one local cohort.
The evidence package fits the ambition. KI is not just screening for interesting kidney data. It is screening for papers that can carry broad nephrology readership.
The editorial operation is mature. Elsevier's infrastructure and the society-backed journal operation are built for quick early handling.
So the journal is fast when the fit question is easy to answer.
What usually slows it down
Kidney International usually feels slower when the fit case is arguable rather than obvious.
The recurring causes of delay are:
- strong renal papers that matter mainly to one subspecialty audience
- observational or biomarker papers whose clinical payoff is still limited
- translational studies where the mechanism is thinner than the title implies
- reviewer requests for more validation or stronger consequence claims before acceptance
In other words, the speed problem is often a journal-level problem disguised as a review problem.
Desk timing and what to do while waiting
If the manuscript has cleared the first desk screen, the waiting period is best used to prepare for the kind of questions KI reviewers and editors usually press hardest.
- sharpen the broad-nephrology relevance in the abstract and rebuttal logic
- prepare concise defenses of clinical or mechanistic consequence
- pressure-test whether the study design really supports the level of claim
- be ready to explain why the paper belongs in KI rather than a narrower renal journal
At KI, waiting well usually means strengthening the breadth argument, not just the sentence polish.
Timing context from the journal's citation position
That context matters because KI does not need to keep borderline manuscripts alive. It can triage hard and still remain one of the head journals in nephrology.
Longer-run journal trend and what it means for timing
For year-over-year citation metrics data, see the kidney international citation metrics page.
The open Scopus-based trend series is down from 6.20 in 2023 to 5.64 in 2024, which mainly shows normalization after a hotter citation cycle. It does not contradict the current flagship position. The JCR rank, JCI, and long citation half-life all still support an elite nephrology posture, which is exactly why the journal can move quickly at the desk.
How Kidney International compares with nearby journals on timing
Journal | Timing signal | Editorial posture |
|---|---|---|
Kidney International | Fast desk screen and disciplined reviewed path | Best for broad nephrology papers with strong clinical or mechanistic consequence |
JASN | High-end society-journal screen with its own editorial taste | Better when the paper fits JASN's specific readership and framing |
CJASN | More clinically practice-facing lane | Better for narrower clinical-nephrology ownership |
Kidney International Reports | Strong renal destination with a different selectivity level | Better for solid nephrology papers below flagship breadth |
This is why many KI timing frustrations are really targeting frustrations. The journal is fast enough. The paper may simply belong one tier lower or one audience narrower.
Readiness check
While you wait, scan your next manuscript.
The scan takes about 1-2 minutes. Use the result to decide whether to revise before the decision comes back.
What review-time data hides
Review-time data hide the central strategic fact.
- An 18-day first-decision number includes a lot of fast editorial sorting.
- A 7-day desk-reject average means the journal is decisive about level.
- The 35-day reviewed path only matters for papers that already look like KI papers.
- Total acceptance timing is reasonable only if the manuscript belongs at this level in the first place.
So the clock is real, but it is not the main decision variable.
What we see in Kidney International manuscripts
The biggest timing mistake is assuming that because KI handles manuscripts efficiently, it is worth trying first with any strong nephrology paper.
That logic wastes time.
The papers that move best here usually have:
- a clearly broad nephrology audience
- a consequence case that reaches beyond one disease niche or modality
- evidence strong enough to support the scale of the claim
- a manuscript that looks like flagship nephrology from page one
Those traits reduce the chance that the fast first decision becomes a fast rejection.
What pre-submission reviews reveal
For Kidney International-targeted manuscripts, three patterns most consistently predict slow review at Kidney International (International Society of Nephrology). Of manuscripts we screened in 2025 targeting Kidney International and peer venues, the patterns below are the same ones our reviewers flag in real time. The named editorial-culture quirk: Kidney International editors emphasize translational nephrology with both mechanistic depth and clinical-application pathway.
Scope-fit ambiguity in the abstract. Kidney International editors move fastest on manuscripts whose contribution is obviously aligned with the journal's editorial scope (nephrology research with mechanistic depth or practice-changing implications for clinical nephrologists). The named failure pattern: mechanism-only nephrology papers without clinical-translation pathway extend revision rounds. Check whether your abstract reads to Kidney International's scope →
Methods package incomplete for the journal's reviewer pool. Kidney International reviewers expect specific methodological detail. Clinical observational studies without mechanistic underpinning extend reviewer consultation. Check if your methods package is reviewer-complete →
Reference-list and clean-citation failure mode. Editorial team at Kidney International (International Society of Nephrology) screens reference lists for retracted-paper inclusion. Check whether your reference list is clean against Crossref + Retraction Watch →
Editorial detail (for desk-screen calibration). Verify the current Editor-in-Chief and handling-editor list on the journal's editorial-team page before quoting any name in a submission cover letter. Submission portal: Editorial Manager submission portal. Manuscript constraints: 300-word abstract limit and 5,000-word main-text cap (Kidney International enforces during desk-screen).
We reviewed each of these constraints against current journal author guidelines (accessed 2026-05-08); evidence basis for the patterns above includes both publicly documented author-guidelines and our internal anonymized submission corpus.
Manusights submission-corpus signal for Kidney International (International Society of Nephrology). Of the manuscripts our team screened before submission to Kidney International and peer venues in 2025, the editorial-culture mismatch most consistent across the cohort is Kidney International editors emphasize translational nephrology with both mechanistic depth and clinical-application pathway.
In our analysis of anonymized Kidney International-targeted submissions, the documented review timeline shows a bimodal distribution between manuscripts that clear Kidney International's scope-fit threshold within the first week and those that get extended editorial-board consultation. Top-line triage is handled by the journal's editorial team; verify the current handling editor on the journal's editorial-team page before quoting any name in a cover letter.
Submit If
- The headline finding fits Kidney International (International Society of Nephrology)'s editorial scope (nephrology research with mechanistic depth or practice-changing implications for clinical nephrologists) and the abstract names that fit within the first 100 words for Kidney International's editorial-team triage.
- The methods section is detailed enough for Kidney International reviewers to evaluate without follow-up; protocol and reproducibility detail are in the main text rather than deferred to supplementary materials.
- The reference list is clean of recently retracted citations.
- A figure or table makes the contribution visible without specialist translation; the cover letter explicitly names the Kidney International-relevant audience the work is aimed at.
Think Twice If
- Mechanism-only nephrology papers without clinical-translation pathway extend revision rounds; this is the named Kidney International desk-screen failure mode our team flags before submission.
- The cover letter spends a paragraph on background before the new finding appears in the abstract; Kidney International's editorial culture treats this as a scope-fit warning.
- The reference list cites a paper that has since been retracted without acknowledging the retraction notice.
- The protocol or methodology section relies on more than 3 figures of supplementary material that should be in the main text for Kidney International's reviewer pool.
What should drive the submission decision instead
For Kidney International, timing matters, but broad nephrology consequence matters more.
That is why the better next reads are:
- Kidney International citation metrics
A Kidney International fit check is usually more useful than trying to optimize around the 18-day headline alone.
Practical verdict
Kidney International review time is one of the clearer flagship-journal timing cases: roughly 18 days to first decision, about 35 days to first reviewed decision, and roughly 114 days to acceptance. That is good operationally. The harder question is whether the paper is truly broad enough for flagship nephrology (based on SciRev reports and publisher guidelines).
The Manusights Kidney International readiness scan. This guide tells you what Kidney International (International Society of Nephrology)'s editors look for in the first 1-2 weeks of triage. The review tells you whether your paper passes that check before you submit.
We have reviewed manuscripts targeting Kidney International (International Society of Nephrology) and peer venues; the named patterns below are the same ones the journal's handling editors and outside reviewers flag at the desk-screen and first-review stages. documented review timeline of approximately 7-10 days for desk-screen. 60-day money-back guarantee. Your manuscript is not used for model training, and access is limited to the review workflow.
Frequently asked questions
Recent official ISN editorial materials report about 18 days from submission to first decision, including desk rejections. The same source indicates editorial rejects average about 7 days.
The same official editorial materials report about 35 days from submission to first decision for reviewed manuscripts and about 114 days from submission to acceptance overall.
Because the journal is efficient at editorial triage. Good but too-narrow renal papers can still be rejected quickly, while genuinely broad nephrology papers move into a structured review path.
Broad nephrology consequence matters most. If the manuscript is mainly a local cohort, narrow biomarker story, or subfield-specific paper, the journal often identifies that early.
Sources
Final step
Done interpreting the status? Put the wait to work.
The decision will arrive on the journal's clock. What you control is what's next: scan your next manuscript free, or run this paper through the scan so the likely reviewer pushback is mapped before the revision request lands.
Free scan, no card needed.
Anthropic Privacy Partner. Your manuscript is never used to train any model.